isocarboxazid has been researched along with Refractory Depression in 1 studies
Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Normal dosage isocarboxazide may be prescribed for all patients because isocarboxazide is not metabolized through the CYP2D6 enzyme complex like most other antidepressants." | 2.52 | [The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression]. ( Brøsen, K; Krogh-Nielsen, L; Larsen, JK, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Larsen, JK | 1 |
| Krogh-Nielsen, L | 1 |
| Brøsen, K | 1 |
1 review available for isocarboxazid and Refractory Depression
| Article | Year |
|---|---|
[The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression].
Topics: Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Diet; Drug Interactions; Edema; Hum | 2015 |